Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-027990
Filing Date
2023-06-14
Accepted
2023-06-14 16:37:59
Documents
2
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6067
2 EX-24.1 dbtx-ex24_1.htm EX-24.1 11949
  Complete submission text file 0000950170-23-027990.txt   19394
Mailing Address C/O ACCELERON PHARMA INC. 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
MCLAUGHLIN KEVIN F (Reporting) CIK: 0001214938 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40030 | Film No.: 231014630

Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Issuer) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations